Thu. Sep 19th, 2024
COVID-19 CRISIS MANAGEMENT
  • EU Health Ministers discuss 4th vaccine shot and COVID-19 crisis management
  • EEA: COVID-19: lessons for sustainability?
  • WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries
  • WHO Europe zur Omikron-Variante: Fakten von Mythen trennen
  • EU Commission: Answer to a written question – ‘Green’ certification in Italy  – E-004702/2021(ASW)
  • COVID-19 Monitoring: Seroepidemiological Studies in Germany
  • RKI Links: Hinweise zur Testung von Patienten auf Infektion mit dem neuartigen Coronavirus SARS-CoV-2
  • UN: Americas: ‘Smart’ use of rapid tests critical amid COVID surge
  • U.S. NIST: RNA Reference Materials Are Useful for Standardizing COVID-19 Tests, Study Shows
  • South Korea: Serological evaluation of patients with coronavirus disease-2019 in Daegu
EMA
  • Health Union: A stronger role for the European Medicines Agency
ASBESTOS
  • EU Commission: Answer to a written question – Asbestos in drinking water – E-005165/2021(ASW)
EU COMMISSION REGISTER
  • COMMISSION DECISION setting up the group of experts on industrial property policy
  • COMMISSION DECISION on the adoption of the list of candidates for submission to the Council and the European Parliament with a view to the appointment of members of the Management Board of the European Food Safety Authority representing the civil society and food chain interests
  • COMMISSION REGULATION (EU) / amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flonicamid in or on certain products
EFSA BRIEFS
  • ERC Advanced Grants
  • Modification of the existing maximum residue level for oxathiapiprolin in kales/radish leaves
  • Modification of the existing maximum residue levels for fosetyl/phosphonic acid in apricots, cherries and plums resulting from the use of potassium phosphonates
  • Modification of existing maximum residue levels in various crops and evaluation of confirmatory data following the Article 12 MRL review for trifloxystrobin

You can read, buy and download the PDF below:




Important note

On this platform, we are publishing our Insight EU Monitoring editions with a delay of several hours. If you want to get our monitoring e-mails in real-time you can subscribe to our full-text services on our IEU Store page.

Please do not hesitate to reach out if you need tailored regulatory monitoring services, focusing on certain policy fields, institutions, or issues. See also our FAQs for further information.

Last, but not least, here are some more interesting deep links:

Forward to your friends